About
Dr. Benjamin Blue is the CEO & Co-Founder of Ora Biomedical, a Seattle-based longevity biotechnology company using AI-driven high-throughput in vivo screening to discover small molecule therapeutics for healthy aging. He holds a PhD in Biomedical Engineering from Johns Hopkins University and has built partnerships with AFWERX/U.S. Air Force and investors including Extropy Ventures. He is a frequent speaker in the longevity ecosystem and an advocate for next-generation science education.
Areas of interest
longevityaging biologydrug discoveryAI-driven screeningsmall molecule therapeuticsbiotechscience educationgeroscience